Table 4.
Secondary outcome assessment self-efficacy for managing chronic disease score; per-protocol analysis.
| Time Periods | Intervention | Control | Difference between groups | |||
| Mean (SD) | n (%) | Mean (SD) | n (%) | d (95% CI) | P value | |
| Baseline/preadmissiona | 6.52 (1.88) | 47 (100) | 6.60 (1.80) | 47 (100) | −0.07 (−0.82 to 0.69) | .86 |
| Change baseline—6 weeksa | 1.29 (2.09) | 37 (35) | 1.51 (1.70) | 42 (98) | −0.22 (−1.06 to 0.63) | .62 |
| Change baseline—3 monthsa | 1.85 (2.06) | 41 (98) | 1.49 (1.67) | 37 (100) | 0.36 (−0.49 to 1.21) | .40 |
| Change baseline—6 monthsa | 2.06 (2.24) | 32 (97) | 1.76 (1.61) | 39 (100) | 0.31 (−0.61 to 1.22) | .51 |
aIndependent t test.